US Stock MarketDetailed Quotes

PPCB PROPANC BIOPHARMA INC

Watchlist

0.000250
0.0000000.00%

15min DelayTrading Nov 27 16:00 ET

197.47KMarket Cap0.00P/E (TTM)

PROPANC BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

-6.06%-238.89K

34.53%-333.46K

23.05%-1.11M

56.70%-177.97K

38.66%-192.74K

-0.40%-225.23K

Net income from continuing operations

-0.98%-354.31K

31.57%-1.82M

52.06%-358.58K

34.96%-526.7K

-20.39%-584.38K

43.16%-350.87K

-0.09%-2.66M

17.32%-748.04K

-75.02%-809.81K

39.32%-485.42K

Operating gains losses

85.42%-22.71K

-96.25%27.54K

-93.60%27.09K

-100.02%-83

348.33%156.26K

-995.43%-155.72K

7.27%733.56K

51.64%423.01K

806.48%356.08K

-113.38%-62.93K

Depreciation and amortization

5.17%5.53K

-5.56%21.66K

3.73%5.76K

-15.09%4.77K

-4.75%5.86K

-6.10%5.26K

304.36%22.93K

33.33%5.56K

1,047.14%5.62K

1,120.04%6.15K

Other non cash items

-5.45%67.03K

-8.71%297.84K

-67.10%48.99K

52.18%82.35K

-12.64%95.61K

414.62%70.89K

-10.58%326.24K

29.26%148.91K

-47.30%54.11K

1,996.13%109.44K

Change In working capital

-28.91%68.94K

-11.67%417.42K

-1,305.61%-104.18K

67.37%336.85K

-57.71%87.77K

36.19%96.98K

182.25%472.59K

-107.77%-7.41K

110.29%201.26K

72.48%207.53K

-Change in receivables

-290.15%-251

88.36%-71

425.49%2.39K

-226.60%-1.49K

35.34%-1.11K

125.24%132

-136.75%-610

198.91%455

-66.84%1.17K

48.87%-1.72K

-Change in prepaid assets

--0

-5,425.94%-116.21K

-1,859.65%-120.83K

432.96%133.62K

118.19%1.63K

-1,586.29%-130.64K

125.31%2.18K

-2,767.91%-6.17K

1,005.78%25.07K

-430.52%-8.98K

-Change in payables and accrued expense

-72.87%59.75K

74.73%531.1K

599.20%31.82K

14.95%197.68K

25.85%81.37K

198.78%220.24K

105.71%303.96K

-106.83%-6.37K

104.71%171.97K

-42.35%64.65K

-Change in other current liabilities

-16.85%-5.88K

-8.77%-21.6K

-18.75%-5.99K

0.84%-4.84K

-8.59%-5.74K

-8.24%-5.03K

-505.95%-19.86K

-53.83%-5.04K

---4.88K

---5.29K

-Change in other working capital

24.78%15.32K

-87.05%24.2K

-219.17%-11.58K

49.75%11.88K

-92.68%11.62K

17.86%12.28K

524.98%186.91K

59.48%9.71K

-27.47%7.93K

1,702.08%158.85K

Cash from discontinued investing activities

Operating cash flow

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

-6.06%-238.89K

34.53%-333.46K

23.05%-1.11M

56.70%-177.97K

38.66%-192.74K

-0.40%-225.23K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-38.43%215.7K

-15.43%941.89K

150.97%250.97K

-75.27%66.64K

9.57%273.93K

-29.11%350.35K

-25.29%1.11M

-73.28%100K

-17.58%269.5K

-29.48%250K

Net issuance payments of debt

-38.43%215.7K

55.67%918.84K

--239K

-41.20%55.56K

82.62%273.93K

1.33%350.35K

-22.99%590.25K

--0

-58.37%94.5K

-41.06%150K

Net common stock issuance

----

-6.69%23.06K

--11.98K

--11.08K

----

-75.11%24.71K

--0

Proceeds from stock option exercised by employees

----

--0

----

-24.00%475K

-33.33%100K

75.00%175K

0.00%100K

Net other financing activities

----

--23.76K

--0

Cash from discontinued financing activities

Financing cash flow

-38.43%215.7K

-15.43%941.89K

150.97%250.97K

-75.27%66.64K

9.57%273.93K

-29.11%350.35K

-25.29%1.11M

-73.28%100K

-17.58%269.5K

-29.48%250K

Net cash flow

Beginning cash position

109.86%21.09K

147.04%10.05K

-93.33%6.22K

192.74%71.65K

-65.84%6.63K

147.04%10.05K

80.35%4.07K

-30.36%93.24K

-66.75%24.48K

-57.67%19.4K

Current changes in cash

-217.32%-19.82K

-19.98%6.78K

88.47%-8.99K

-147.11%-36.17K

41.46%35.04K

211.88%16.89K

-84.46%8.47K

-112.39%-77.97K

500.33%76.76K

-80.97%24.77K

Effect of exchange rate changes

139.38%8K

271.30%4.26K

556.90%23.86K

-265.82%-29.26K

252.24%29.98K

-166.76%-20.31K

95.28%-2.49K

94.39%-5.22K

-116.85%-8K

80.76%-19.69K

End cash Position

39.89%9.27K

109.86%21.09K

-93.33%6.22K

192.74%71.65K

-65.84%6.63K

147.04%10.05K

-30.36%93.24K

-66.75%24.48K

Free cash flow

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

-6.06%-238.89K

34.53%-333.46K

23.05%-1.11M

56.70%-177.97K

38.66%-192.74K

-0.40%-225.23K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K	-6.06%-238.89K	34.53%-333.46K	23.05%-1.11M	56.70%-177.97K	38.66%-192.74K	-0.40%-225.23K
Net income from continuing operations	-0.98%-354.31K	31.57%-1.82M	52.06%-358.58K	34.96%-526.7K	-20.39%-584.38K	43.16%-350.87K	-0.09%-2.66M	17.32%-748.04K	-75.02%-809.81K	39.32%-485.42K
Operating gains losses	85.42%-22.71K	-96.25%27.54K	-93.60%27.09K	-100.02%-83	348.33%156.26K	-995.43%-155.72K	7.27%733.56K	51.64%423.01K	806.48%356.08K	-113.38%-62.93K
Depreciation and amortization	5.17%5.53K	-5.56%21.66K	3.73%5.76K	-15.09%4.77K	-4.75%5.86K	-6.10%5.26K	304.36%22.93K	33.33%5.56K	1,047.14%5.62K	1,120.04%6.15K
Other non cash items	-5.45%67.03K	-8.71%297.84K	-67.10%48.99K	52.18%82.35K	-12.64%95.61K	414.62%70.89K	-10.58%326.24K	29.26%148.91K	-47.30%54.11K	1,996.13%109.44K
Change In working capital	-28.91%68.94K	-11.67%417.42K	-1,305.61%-104.18K	67.37%336.85K	-57.71%87.77K	36.19%96.98K	182.25%472.59K	-107.77%-7.41K	110.29%201.26K	72.48%207.53K
-Change in receivables	-290.15%-251	88.36%-71	425.49%2.39K	-226.60%-1.49K	35.34%-1.11K	125.24%132	-136.75%-610	198.91%455	-66.84%1.17K	48.87%-1.72K
-Change in prepaid assets	--0	-5,425.94%-116.21K	-1,859.65%-120.83K	432.96%133.62K	118.19%1.63K	-1,586.29%-130.64K	125.31%2.18K	-2,767.91%-6.17K	1,005.78%25.07K	-430.52%-8.98K
-Change in payables and accrued expense	-72.87%59.75K	74.73%531.1K	599.20%31.82K	14.95%197.68K	25.85%81.37K	198.78%220.24K	105.71%303.96K	-106.83%-6.37K	104.71%171.97K	-42.35%64.65K
-Change in other current liabilities	-16.85%-5.88K	-8.77%-21.6K	-18.75%-5.99K	0.84%-4.84K	-8.59%-5.74K	-8.24%-5.03K	-505.95%-19.86K	-53.83%-5.04K	---4.88K	---5.29K
-Change in other working capital	24.78%15.32K	-87.05%24.2K	-219.17%-11.58K	49.75%11.88K	-92.68%11.62K	17.86%12.28K	524.98%186.91K	59.48%9.71K	-27.47%7.93K	1,702.08%158.85K
Cash from discontinued investing activities
Operating cash flow	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K	-6.06%-238.89K	34.53%-333.46K	23.05%-1.11M	56.70%-177.97K	38.66%-192.74K	-0.40%-225.23K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-38.43%215.7K	-15.43%941.89K	150.97%250.97K	-75.27%66.64K	9.57%273.93K	-29.11%350.35K	-25.29%1.11M	-73.28%100K	-17.58%269.5K	-29.48%250K
Net issuance payments of debt	-38.43%215.7K	55.67%918.84K	--239K	-41.20%55.56K	82.62%273.93K	1.33%350.35K	-22.99%590.25K	--0	-58.37%94.5K	-41.06%150K
Net common stock issuance	----	-6.69%23.06K	--11.98K	--11.08K	----	----	-75.11%24.71K	--0	--0	--0
Proceeds from stock option exercised by employees	----	--0	--0	--0	----	----	-24.00%475K	-33.33%100K	75.00%175K	0.00%100K
Net other financing activities	----	----	----	----	----	----	--23.76K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-38.43%215.7K	-15.43%941.89K	150.97%250.97K	-75.27%66.64K	9.57%273.93K	-29.11%350.35K	-25.29%1.11M	-73.28%100K	-17.58%269.5K	-29.48%250K
Net cash flow
Beginning cash position	109.86%21.09K	147.04%10.05K	-93.33%6.22K	192.74%71.65K	-65.84%6.63K	147.04%10.05K	80.35%4.07K	-30.36%93.24K	-66.75%24.48K	-57.67%19.4K
Current changes in cash	-217.32%-19.82K	-19.98%6.78K	88.47%-8.99K	-147.11%-36.17K	41.46%35.04K	211.88%16.89K	-84.46%8.47K	-112.39%-77.97K	500.33%76.76K	-80.97%24.77K
Effect of exchange rate changes	139.38%8K	271.30%4.26K	556.90%23.86K	-265.82%-29.26K	252.24%29.98K	-166.76%-20.31K	95.28%-2.49K	94.39%-5.22K	-116.85%-8K	80.76%-19.69K
End cash Position	39.89%9.27K	109.86%21.09K	109.86%21.09K	-93.33%6.22K	192.74%71.65K	-65.84%6.63K	147.04%10.05K	147.04%10.05K	-30.36%93.24K	-66.75%24.48K
Free cash flow	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K	-6.06%-238.89K	34.53%-333.46K	23.05%-1.11M	56.70%-177.97K	38.66%-192.74K	-0.40%-225.23K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data